Diary - News All news PDC*line Pharma raises €4 million

PDC*line Pharma raises €4 million

PDC*line Pharma raises €4 million ($4.24M) in a first round and appoints Eric Halioua as president and CEO

Three Belgian investment funds and several specialized international business angels have participated in this round, which will allow the company’s cancer immunotherapy technology to reach the clinical proof of concept phase.

Read the press release

To go further...

See PDC*line Pharma profil

Headlines

Our members

Osivax Announces Publication of Phase 1 Data on its Broad-Spectrum Influenza Vaccine Candidate OVX836

Décember 3^th, 2021

Poxel annonce la création d’un Conseil Scientifique dédié aux maladies métaboliques rares

Décember 6^th, 2021

ADVANCED BIODESIGN, LAUREAT DU CONCOURS D’INNOVADVANCED BIODESIGN, WINNER OF THE I-NOV INNOVATION COMPETITION (WAVE 7)

November 22^th, 2021

All news